Home > Income Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Consolidated Net Profit

    Back to Income Statement
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹-1,502 Cr₹297 Cr₹942 Cr₹970 Cr₹776 Cr

What is the latest Consolidated Net Profit of GLENMARK PHARMACEUTICALS ?

The latest Consolidated Net Profit ratio of GLENMARK PHARMACEUTICALS is ₹-1,502 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹-1,502 Cr
Mar2024₹297 Cr
Mar2023₹942 Cr
Mar2022₹970 Cr
Mar2021₹776 Cr

How is Consolidated Net Profit of GLENMARK PHARMACEUTICALS Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹-1,502 Cr
Negative
Mar2024 ₹297 Cr
-68.44
Mar2023 ₹942 Cr
-2.92
Mar2022 ₹970 Cr
25.01
Mar2021 ₹776 Cr -

Compare Consolidated Net Profit of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹56,764.5 Cr -4.9% 1.8% 26.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,019.0 Cr -3% -3.6% -4.9% Stock Analytics
DIVIS LABORATORIES ₹168,752.0 Cr -3.1% 0.1% 11.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,542.0 Cr -3.7% 4% 18.8% Stock Analytics
CIPLA ₹115,883.0 Cr -1.3% -4.6% -1.5% Stock Analytics
DR REDDYS LABORATORIES ₹99,024.7 Cr -4.2% -7% -11.4% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-4.9%

1.8%

26.7%

SENSEX

-1.9%

-2.2%

7.4%


You may also like the below Video Courses